BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Erlotinib
1
Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis
3/22/2024 11:13:53 AM | Browse: 168 | Download: 734
2
Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival
2/21/2024 9:11:33 AM | Browse: 323 | Download: 1348
3
Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
8/24/2021 2:07:00 AM | Browse: 539 | Download: 1846
4
Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
3/6/2019 8:51:28 AM | Browse: 992 | Download: 1807
5
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1339 | Download: 2024
6
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
12/11/2014 2:06:00 PM | Browse: 1089 | Download: 1562
7
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
9/15/2014 8:54:00 PM | Browse: 1371 | Download: 1317
8
FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer
9/15/2014 4:56:00 PM | Browse: 1245 | Download: 1500
9
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1314 | Download: 1561
10
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells
8/26/2014 1:51:00 PM | Browse: 1121 | Download: 1203
11
Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts
8/20/2014 6:38:00 PM | Browse: 1509 | Download: 1472
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345